Download year list
Thumb Download Description
Corporate governance in Novozymes (opens in new window)

Easy access to find our reporting on corporate governance in our latest annual report

Board of directors (opens in new window)

Read more about the requirements to our board of directors and how the board is comprised

Leadership team (opens in new window)

Read more about the rules of procedure for our leadership team

Shareholders’ meeting (opens in new window)

The annual shareholder’s meeting ensures the basic right of shareholders to receive information and participate in key decisions regarding Novozymes

Articles of association and reports on corporate governance (opens in new window)

Read more about the purpose of Novozymes and how we comply with the recommendations on corporate governance

Position on business integrity (opens in new window)

Novozymes’ position on business integrity rests on six integrity principles to which all employees, including executives, officers and directors, must adhere. Read more about them here

Novozymes' whistleblower hotline - report your concern (opens in new window)

If you become aware of illegal or unethical misconduct, we strongly encourage you to report it to Novozymes either through your regular channels of communication or using Novozymes' Whistleblower Hotline

Corporate governance at Novozymes

Corporate governance refers to the way a company is lead and controlled. Novozymes' values are consistent with the principles of good governance.

The Board of Directors and Executive Leadership Team of Novozymes believe that corporate governance initiatives should be a constant process and address the principles of good corporate governance in an ongoing process with due consideration to current legislation, practice and recommendations. Such evaluation includes a review of the company’s business concept, business procedures, goals, organization, capital position, stakeholder relations, risks and the exercise of control.

This section describes corporate governance at Novozymes in relation to shareholder meetings, the Board of Directors, and Executive Leadership Team, as well as includes the statutory report on corporate governance.

Corporate governance compliance

Once a year the Board of Directors considers the Danish Committee on Corporate Governance’s recommendations for good corporate governance.

As required for a listed company on Nasdaq OMX Nordic under the rules for issuers of shares Novozymes issues a statement of compliance with the Danish Committee on Corporate Governance's recommendations using the "comply or explain"-principle. Novozymes’ position on the individual recommendations is described here.